HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seigo Kinuya Selected Research

Neuroblastoma

1/2023[A Report on Health Resource Use of Internal Radiation Therapy with 131I-MIBG (2nd Survey)].
1/2022Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation.
1/2022Application of a tungsten apron for occupational radiation exposure in nursing care of children with neuroblastoma during 131I-meta-iodo-benzyl-guanidine therapy.
6/2021Comparison of the detecting capability between 123I-mIBG and post-therapeutic 131I-mIBG scintigraphy for curie scoring in patients with neuroblastoma after chemotherapy.
1/2021[Radiation Protection Against Exposure from Patients Receiving 131I-MIBG and Released from Radiation Treatment Room].
11/2020High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience.
9/2020Diagnostic Use of Post-therapy 131I-Meta-Iodobenzylguanidine Scintigraphy in Consolidation Therapy for Children with High-Risk Neuroblastoma.
6/2020Radiation exposure in nurses during care of 131I-MIBG therapy for pediatric patients with high-risk neuroblastoma.
6/2020High-dose 131I-metaiodobenzylguanidine therapy in patients with high-risk neuroblastoma in Japan.
8/2018Current Consensus on I-131 MIBG Therapy.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seigo Kinuya Research Topics

Disease

50Neoplasms (Cancer)
04/2024 - 08/2002
27Neoplasm Metastasis (Metastasis)
03/2023 - 12/2002
20Pheochromocytoma
01/2023 - 02/2008
18Thyroid Neoplasms (Thyroid Cancer)
03/2023 - 04/2004
18Neuroblastoma
01/2023 - 09/2003
17Prostatic Neoplasms (Prostate Cancer)
05/2024 - 11/2013
13Paraganglioma (Paragangliomas)
01/2023 - 01/2011
9Neuroendocrine Tumors (Neuroendocrine Tumor)
04/2022 - 02/2008
8Colonic Neoplasms (Colon Cancer)
02/2007 - 08/2002
7Ischemia
01/2015 - 09/2004
5Myocardial Ischemia (Ischemic Heart Diseases)
01/2023 - 07/2010
5Breast Neoplasms (Breast Cancer)
08/2022 - 11/2003
5Pain (Aches)
06/2020 - 01/2007
4Colorectal Neoplasms (Colorectal Cancer)
02/2005 - 12/2002
3Cardiomyopathies (Cardiomyopathy)
12/2023 - 01/2013
3Carcinoma (Carcinomatosis)
03/2021 - 09/2003
3Myocardial Infarction
02/2021 - 03/2013
3Alzheimer Disease (Alzheimer's Disease)
11/2020 - 12/2007
3Hyperthyroidism
12/2014 - 04/2004
3Graves Disease (Basedow Disease)
08/2007 - 04/2004
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2022 - 03/2021
2Lewy Body Disease (Lewy Body Dementia)
08/2022 - 04/2018
2Diabetes Mellitus
01/2022 - 11/2013
2Hypertension (High Blood Pressure)
01/2022 - 11/2013
2Ventricular Remodeling
02/2021 - 01/2015
2Ganglioneuroblastoma
11/2020 - 09/2020
2Pathologic Constriction (Stenosis)
10/2018 - 08/2009
2Heart Failure
04/2018 - 10/2010
2Osteosarcoma (Osteogenic Sarcoma)
01/2016 - 08/2012
2MELAS Syndrome (Syndrome, MELAS)
01/2013 - 01/2008
2Leukemia
02/2006 - 11/2004
2Peritoneal Neoplasms
02/2005 - 07/2003
2Hypoxia (Hypoxemia)
11/2003 - 08/2002

Drug/Important Bio-Agent (IBA)

183-Iodobenzylguanidine (Iobenguane)IBA
03/2022 - 12/2008
9Radioisotopes (Radionuclides)IBA
10/2023 - 02/2002
8Radium-223IBA
04/2021 - 10/2017
7Therapeutic UsesIBA
04/2024 - 07/2004
7LigandsIBA
03/2024 - 11/2009
7Iodine-131IBA
01/2023 - 09/2003
5RadiopharmaceuticalsIBA
05/2024 - 01/2007
51,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
04/2024 - 04/2019
5Peptides (Polypeptides)IBA
01/2022 - 01/2018
5Thallium-201IBA
11/2019 - 09/2003
5Monoclonal AntibodiesIBA
09/2010 - 08/2002
5Immunoglobulin G (IgG)IBA
02/2005 - 08/2002
4sigma Receptors (sigma Receptor)IBA
07/2023 - 11/2009
4arginyl-glycyl-aspartic acidIBA
12/2022 - 01/2018
4iodofiltic acidIBA
11/2022 - 01/2005
4Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
06/2020 - 12/2007
4IodineIBA
01/2015 - 11/2011
3AntigensIBA
05/2024 - 11/2022
3Technetium Tc 99m PyrophosphateIBA
12/2023 - 12/2022
3Prealbumin (Transthyretin)IBA
12/2023 - 12/2022
3Peptide Receptors (Peptide Receptor)IBA
10/2023 - 12/2021
3Tyrosine Kinase InhibitorsIBA
10/2022 - 08/2018
3Somatostatin Receptors (Somatostatin Receptor)IBA
12/2021 - 11/2018
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2013 - 11/2004
3Technetium Tc 99m Sestamibi (Cardiolite)FDA LinkGeneric
01/2008 - 11/2003
3Messenger RNA (mRNA)IBA
02/2006 - 11/2004
2AlbuminsIBA
04/2024 - 12/2022
2Amyloid (Amyloid Fibrils)IBA
12/2023 - 12/2023
2diphosphoric acid (pyrophosphoric acid)IBA
12/2023 - 12/2023
2Fluorouracil (Carac)FDA LinkGeneric
10/2023 - 02/2005
2Sigma-1 ReceptorIBA
01/2023 - 10/2021
2CatecholaminesIBA
01/2023 - 01/2022
2cyclopentanolIBA
01/2023 - 10/2021
2AcidsIBA
12/2022 - 10/2010
2GalliumIBA
12/2022 - 04/2019
2Lysine (L-Lysine)FDA Link
12/2022 - 11/2022
2Aspartic Acid (Aspartate)FDA Link
12/2022 - 11/2022
2ErbB Receptors (EGF Receptor)IBA
10/2022 - 06/2020
2vesamicolIBA
08/2022 - 11/2009
2SolutionsIBA
12/2021 - 12/2009
2IntegrinsIBA
10/2021 - 01/2018
2Fatty Acids (Saturated Fatty Acids)IBA
01/2021 - 01/2005
2Methionine (L-Methionine)FDA Link
11/2019 - 03/2013
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2019 - 08/2018
2Norepinephrine (Noradrenaline)FDA LinkGeneric
08/2018 - 01/2015
2Neurotransmitter Agents (Neurotransmitter)IBA
08/2018 - 10/2010
2TenascinIBA
01/2015 - 07/2010
2Human Serum AlbuminFDA LinkGeneric
11/2011 - 09/2003
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2010 - 11/2006
2strontium chloride (strontium chloride Sr 89)FDA LinkGeneric
05/2009 - 06/2007
22-MethoxyestradiolIBA
12/2005 - 07/2004
2Proteins (Proteins, Gene)FDA Link
06/2004 - 11/2003
2multidrug resistance-associated protein 1IBA
06/2004 - 11/2003
1gallium 68 PSMA-11IBA
05/2024
1SodiumIBA
04/2024
1AstatineIBA
03/2024

Therapy/Procedure

60Therapeutics
03/2024 - 08/2002
15Drug Therapy (Chemotherapy)
01/2022 - 02/2005
11Castration
03/2024 - 10/2017
9Radiotherapy
01/2023 - 09/2003
8Radioimmunotherapy
02/2007 - 08/2002
5Precision Medicine
01/2023 - 01/2022
2Aftercare (After-Treatment)
10/2023 - 10/2012
2Injections
05/2019 - 10/2017
2Neoadjuvant Therapy
08/2012 - 12/2009
2Intravenous Injections
11/2009 - 08/2002
2Intraperitoneal Injections
02/2007 - 07/2003